Concomitant Peripheral Arterial Disease and Coronary Artery Disease

Bittl, John A.; Hirsch, Alan T.

doi:10.1161/01.cir.0000132612.07145.25

Cited by 27 publications

(13 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These are high-risk patients with high morbidity and mortality; hence, their management requires comprehensive multi-specialty cardiovascular approach and global revascularization [6][7][8]. In the reported case, all the interventions including peripheral artery revascularization was done by cardiologists.…”

Section: Discussionmentioning

confidence: 95%

See 1 more Smart Citation

Concomitant congenital, atherosclerotic coronary and peripheral artery disease: Managed with percutaneous interventions

Vijayvergiya

Kubba

Grover

2006

International Journal of Cardiology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 95%

“…On the other hand, the presence of atherosclerotic coronary and peripheral artery disease is frequent in the elderly population [6,7]. The index case is unique because of the presence of coronary and peripheral artery disease along with severe pulmonic stenosis.…”

Section: Discussionmentioning

confidence: 99%

Concomitant congenital, atherosclerotic coronary and peripheral artery disease: Managed with percutaneous interventions

Vijayvergiya

Kubba

Grover

2006

International Journal of Cardiology

View full text Add to dashboard Cite

“…We excluded one patient described by Pun et al . and one patient described by Bittl and Hirsch because they did not fulfil our inclusion criteria. There were no cases described in more than one report.…”

Section: Resultsmentioning

confidence: 99%

The efficacy of renal angioplasty in patients with renal artery stenosis and flash oedema or congestive heart failure: a systematic review

Berg¹,

Deinum²,

Postma³

et al. 2012

European J of Heart Fail

View full text Add to dashboard Cite

AimsRecent randomized controlled trials have reported that angioplasty does not have a beneficial effect compared with pharmacological treatment on blood pressure and renal function in patients with atherosclerotic renal artery stenosis (RAS). We aimed to explore systematically the evidence that angioplasty is effective in subgroups of patients with RAS and either flash pulmonary oedema or congestive heart failure (CHF) and renal insufficiency. Methods and resultsWe searched online databases (PubMed and ClinicalTrials.gov) and references of included articles. We included 25 articles describing 79 patients with RAS and flash oedema and seven articles describing 94 patients with RAS, CHF, and renal insufficiency. According to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system, the quality of the evidence was, at best, low. Seventy-six per cent of patients with flash oedema did not have any recurrence after angioplasty. Recurrence of symptoms was associated with either restenosis of the renal artery or cardiac arrhythmias in all patients. In the patients with CHF and renal insufficiency, the severity of heart failure symptoms, expressed as New York Heart Association (NYHA) functional class, improved after angioplasty in all included articles. ConclusionThe evidence included in this systematic review justifies a weak recommendation in favour of angioplasty in patients with atherosclerotic RAS and either flash pulmonary oedema or CHF and renal insufficiency.--

show abstract

“…These are the high risk patients with high morbidity and mortality; hence their management requires comprehensive multi-specialty approach and also the global revascularization [20][21][22]. In the index case, we consulted experts from the gastroenterology, neurology, nephrology, radiology and vascular surgery departments for comprehensive management.…”

Section: Discussionmentioning

confidence: 99%